New Immunotherapy for Patients With Multiple Myeloma
A Bristol Myers Squibb promotional program:
A new immunotherapy for patients with relapsed/refractory multiple myeloma
Presented by: Joshua Sasine, M.D. UCLA – Los Angeles, CA
Please contact Program Registration at email@example.com / (866) 991-3694 and provide your name, degree, office address, phone number, and email address. Upon registration, you will receive further program details.
For questions, please contact your Bristol Myers Squibb representative, Allen Tchoi at (415) 385-3861.